跳至主要内容
临床试验/KCT0001353
KCT0001353已完成未知

A human study for investigating effects of Acanthopanax koreanum Nakai extract consumption on hepatic function in moderate drinkers

Jeju Technopark0 个研究点目标入组 69 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) Wiling to provide own written informed consent to trial participation
  • 2) Adult male & female = 20 years
  • 3) Moderate drinkers
  • - Male: = 210g of alcohol/week
  • - Female: = 140g of alcohol/week
  • 4) gamma-Glutamyl Transpeptidase(GGT) = 60 IU/L
  • 5) Proven fatty liver (liver ultrasound)

排除标准

  • 1) More than or equal to 420 g of alcohol/week
  • 2) Serum alanine Transaminase, aspartate Transaminase or total bilirubin > 5 x upper normal limit
  • 3) Following past medical history
  • ? Viral hepatitis (HBsAg+, HCV-Ab+), liver failure, primary biliary cirrhosis, drug-induced liver disease, biliary disease, autoimmune liver disease, surgery-induced liver disease, hereditary liver disease
  • ? Systemic inflammation(tuberculosis), severe cardiovascular, digestive, renal, thyroid disease, autoimmune disease, malignant neoplasm, multisystem failure, inflammatory bowel disease, psychiatric disease, HIV positive, uncontrolled hypertension
  • 4) Organ or bone marrow transplant recipient
  • 5) Gastro-intestinal surgery (except appendectomy)
  • 6) Concomittent medications
  • ? Anti-tuberculosis, Non-steroidal anti-Inflammatory drugs, antibiotics: isoniazid, rifampin etc.
  • ? Cholagogues: choline orotate, chenodeoxycholic acid, ursodeoxycholic acid etc.
  • ? Liver pills: biphenyl-dimethyl-dicarboxylate, ornithine HCL, silymarin, carnitine orotate, citiolone, arginine thiazolidine carboxylate, coriolan, urazamide, ornithine arspartate, arginine tidiacicate, metadoxine, silybin, malotilate, timonacic etc.
  • ? Hepatotoxic drugs: acetaminophen, amoxicillin, amiodarone, chlorpromazine, ciprofloxacin, diclofenac, erythromycin, fluconazole, methyldopa, oral contraceptives, phenytoin, rifampin etc.
  • ? Anti-epileptics: cytochrom P450 inducer, phenobarbital etc.
  • 7) Continuous consumption of health functional foods (antioxydant vitamin, Oriental Raisin Tree, Anthocyanin, Lentinula edodes, Milk Thistle) within 8 weeks prior to first visit
  • 8) Continuous consumption herbal medicines
  • 9) Hypersensitivity to Acanthopanax koreanum Nakai extract
  • 10) Participation of other clinical study within 12 weeks prior to first visit
  • 11) Pregnant, lactating, child-bearing age women
  • 12) Ineligible for study participation due to other reasons, according to the investigator’s judgment

研究者

相似试验

A human study for investigating effects of... | 临床试验